about
Chemistry and biology of the polyene macrolide antibioticsFluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B.Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells.Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats.Stability of amphotericin B in fungal culture media.Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta.Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patientsSensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard.Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil functionMicroassay foramphotericin BUniform susceptibility of various strains of Coccidioides immitis to amphotericin B.Amphotericin B pharmacokinetics in humans.Combination antifungal therapy for cryptococcal meningitisEffect of rapid intravenous infusion on serum concentrations of amphotericin B.Pharmacokinetics of amphotericin B and flucytosine.Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B.Chemistry and biology of the polyene macrolide antibiotics.Patterns of amphotericin B killing kinetics against seven Candida species.In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B.Effect of amphotericin B and clotrimazole on lymphocyte stimulation.Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients.Liposomal Formulation Decreases Toxicity of Amphotericin B In Vitro and In Vivo.Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability.
P2860
Q24564296-7BD39F6A-329E-4A5F-9250-20BC11078510Q33593689-AA09BF6B-5184-4BE4-A1B6-0C6DA8B31B47Q33690848-2B6C5D91-FC8E-4C08-93B0-6EAEBB3F90A9Q33838940-310A9DA0-FA97-4955-8ADA-02FB9041BCD5Q34265019-1E3BAAE5-5074-4C06-BD73-E9EFEED6876BQ34948668-79568D03-6537-4F23-900F-6D94E4899FD5Q34987807-210C326F-1F44-4C11-87A8-ADD21A7B1172Q35122168-E1387DEC-32B6-444C-8BC8-AB9B52F298BEQ35136556-D5E338AA-63EE-4E9A-990D-EDF20644FC89Q35649592-176FC645-99ED-470F-A3ED-AFC8AD288F44Q35672210-AA55213E-92A1-49A0-B35A-A4FF88FDA7F7Q36458370-F352A55C-ABC0-4371-A102-FD775FF757F3Q36463923-9DFF3373-4D2B-4F1E-93C8-4E4ACEC5E439Q36466609-FF1A6D52-ED79-4E22-8254-DB485DE0AE83Q36811773-E37AC267-E116-4B30-8970-8AF697B44BE0Q37148929-D0D075BE-8728-46E2-BA78-BC9A335E47A8Q39094142-6A4418E0-DD79-44EF-BF7A-DA0FB2500FFDQ39557905-05A7824B-67EB-4CCE-BBFA-B6AED23905F1Q39879878-AA419BE5-2319-4907-A9CB-921C889CFDB2Q40968227-882591A4-5B57-4056-B5D5-90C0A3571C5BQ41028420-B0E2E010-4820-40C3-A072-46537D5502D5Q41030761-8EBB9752-F613-4131-8837-A3D8661CD960Q41261566-1EBED5B7-95E1-44A1-AF19-7D6CCA1D783BQ41388536-19E1CB1F-4167-41D2-84C6-315C79A7F57BQ41870780-36CB8F52-7715-40FD-944C-AB6045608254
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1970
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amphotericin B serum concentrations during therapy.
@en
Amphotericin B serum concentrations during therapy.
@nl
type
label
Amphotericin B serum concentrations during therapy.
@en
Amphotericin B serum concentrations during therapy.
@nl
prefLabel
Amphotericin B serum concentrations during therapy.
@en
Amphotericin B serum concentrations during therapy.
@nl
P2093
P2860
P1433
P1476
Amphotericin B serum concentrations during therapy.
@en
P2093
Abernathy RS
Fields BT Jr
P2860
P304
P577
1970-06-01T00:00:00Z